Outcomes and Risk Factors of Interventions for Pediatric Post-operative Pulmonary Vein Stenosis
- PMID: 37422845
- DOI: 10.1007/s00246-023-03214-w
Outcomes and Risk Factors of Interventions for Pediatric Post-operative Pulmonary Vein Stenosis
Abstract
Pulmonary vein stenosis (PVS) in children is a challenging condition with poor outcomes. Post-operative stenosis can occur after repair of anomalous pulmonary venous return (APVR) or stenosis within native veins. There is limited data on the outcomes of post-operative PVS. Our objective was to review our experience and assess surgical and transcatheter outcomes. Single-center retrospective study was performed including patients < 18 years who developed restenosis after baseline pulmonary vein surgery that required additional intervention(s) from 1/2005 to 1/2020. Non-invasive imaging, catheterization and surgical data were reviewed. We identified 46 patients with post-operative PVS with 11 (23.9%) patient deaths. Median age at index procedure was 7.2 months (range 1 month-10 years), and median follow-up was 10.8 months (range 1 day-13 years). Index procedure was surgical in 36 (78.3%) and transcatheter in 10 (21.7%). Twenty-three (50%) patients developed vein atresia. Mortality was not associated with number of affected veins, vein atresia, or procedure type. Single ventricle physiology, complex congenital heart disease (CCHD), and genetic disorders were associated with mortality. Survival rate was higher in APVR patients (p = 0.03). Patients with three or more interventions had a higher survival rate compared to patients with 1-2 interventions (p = 0.02). Male gender, necrotizing enterocolitis, and diffuse hypoplasia were associated with vein atresia. In post-operative PVS, mortality is associated with CCHD, single ventricle physiology, and genetic disorders. Vein atresia is associated with male gender, necrotizing enterocolitis, and diffuse hypoplasia. Multiple repeated interventions may offer a patient survival benefit; however, larger prospective studies are necessary to elucidate this relationship further.
Keywords: Cardiac surgery; Catheterization; Congenital heart disease; Outcomes; Pulmonary vein stenosis.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Midterm results and risk factors of functional single ventricles with extracardiac total anomalous pulmonary venous connection.Gen Thorac Cardiovasc Surg. 2019 Nov;67(11):941-948. doi: 10.1007/s11748-019-01141-3. Epub 2019 May 27. Gen Thorac Cardiovasc Surg. 2019. PMID: 31134530
-
Hybrid Pulmonary Vein Stenting in Infants with Refractory to Surgical Pulmonary Vein Stenosis Repair.Pediatr Cardiol. 2018 Dec;39(8):1642-1649. doi: 10.1007/s00246-018-1944-2. Epub 2018 Aug 13. Pediatr Cardiol. 2018. PMID: 30105463
-
Hybrid Interventions for Pulmonary Vein Stenosis: Leveraging Intraoperative Endovascular Adjuncts in Challenging Clinical Scenarios.World J Pediatr Congenit Heart Surg. 2024 Nov;15(6):703-713. doi: 10.1177/21501351241247503. Epub 2024 May 23. World J Pediatr Congenit Heart Surg. 2024. PMID: 38780412
-
Postrepair Pulmonary Vein Stenosis: Addressing Anatomic and Patient Risk Factors to Improve Outcomes.Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2025;28:107-116. doi: 10.1053/j.pcsu.2025.02.008. Epub 2025 Feb 26. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2025. PMID: 40382114 Review.
-
Intraluminal Pulmonary Vein Stenosis in Children: A "New" Lesion.Anesth Analg. 2019 Jul;129(1):27-40. doi: 10.1213/ANE.0000000000003924. Anesth Analg. 2019. PMID: 30451723 Review.
Cited by
-
Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy: An Official American Thoracic Society Clinical Practice Guideline.Am J Respir Crit Care Med. 2025 Feb;211(2):157-173. doi: 10.1164/rccm.202410-1901ST. Am J Respir Crit Care Med. 2025. PMID: 39531626 Free PMC article.
-
Risk and Prognostic Factors for Bloodstream Infections Due to Clonally Transmitted Acinetobacter baumannii ST2 with armA, blaOXA-23, and blaOXA-66: A Retrospective Study.Infect Drug Resist. 2025 Apr 14;18:1867-1879. doi: 10.2147/IDR.S498212. eCollection 2025. Infect Drug Resist. 2025. PMID: 40255460 Free PMC article.
-
Cardiogenic Necrotizing Enterocolitis in Infants with Congenital Heart Disease: A Systematic Review and Meta-analysis.Pediatr Cardiol. 2024 Oct 29. doi: 10.1007/s00246-024-03686-4. Online ahead of print. Pediatr Cardiol. 2024. PMID: 39467858
References
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials